Zhejiang Xinguang Pharmaceutical Co Ltd Asset Resilience Ratio
Zhejiang Xinguang Pharmaceutical Co Ltd asset resilience ratio. Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has an Asset Resilience Ratio of 44.77% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zhejiang Xinguang Pharmaceutical Co Ltd (300519) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zhejiang Xinguang Pharmaceutical Co Ltd (2016–2024)
Asset resilience ratio of Zhejiang Xinguang Pharmaceutical Co Ltd from 2016 to 2024. This chart shows how Zhejiang Xinguang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Zhejiang Xinguang Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Xinguang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Zhejiang Xinguang Pharmaceutical Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥400.00 Million | 44.77% |
| Total Liquid Assets | CN¥400.00 Million | 44.77% |
Asset Resilience Insights
- Very High Liquidity: Zhejiang Xinguang Pharmaceutical Co Ltd maintains exceptional liquid asset reserves at 44.77% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Xinguang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Xinguang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Zhejiang Xinguang Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2016–2024)
Zhejiang Xinguang Pharmaceutical Co Ltd asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Zhejiang Xinguang Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 20.33% | CN¥185.00 Million ≈ $27.07 Million |
CN¥909.78 Million ≈ $133.13 Million |
+3.68pp |
| 2023-12-31 | 16.66% | CN¥155.00 Million ≈ $22.68 Million |
CN¥930.41 Million ≈ $136.15 Million |
+4.65pp |
| 2022-12-31 | 12.01% | CN¥115.00 Million ≈ $16.83 Million |
CN¥957.76 Million ≈ $140.15 Million |
-1.40pp |
| 2021-12-31 | 13.41% | CN¥125.00 Million ≈ $18.29 Million |
CN¥932.40 Million ≈ $136.44 Million |
+3.86pp |
| 2020-12-31 | 9.54% | CN¥85.00 Million ≈ $12.44 Million |
CN¥890.79 Million ≈ $130.35 Million |
-15.77pp |
| 2019-12-31 | 25.32% | CN¥218.00 Million ≈ $31.90 Million |
CN¥861.13 Million ≈ $126.01 Million |
+3.67pp |
| 2018-12-31 | 21.64% | CN¥178.00 Million ≈ $26.05 Million |
CN¥822.50 Million ≈ $120.36 Million |
-0.03pp |
| 2017-12-31 | 21.68% | CN¥168.00 Million ≈ $24.58 Million |
CN¥775.05 Million ≈ $113.41 Million |
+0.28pp |
| 2016-12-31 | 21.40% | CN¥150.00 Million ≈ $21.95 Million |
CN¥700.95 Million ≈ $102.57 Million |
-- |
About Zhejiang Xinguang Pharmaceutical Co Ltd
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquar… Read more